{
    "Trade/Device Name(s)": [
        "PLAC\u00ae Test Reagent Kit"
    ],
    "Submitter Information": "diaDexus, Inc.",
    "510(k) Number": "K101853",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062234"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOE"
    ],
    "Summary Letter Date": "November 23, 2010",
    "Summary Letter Received Date": "November 24, 2010",
    "Submission Date": "June 30, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.5600"
    ],
    "Regulation Name(s)": [
        "Low-density lipoprotein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lipoprotein-associated phospholipase A2 (Lp-PLA2)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "KEDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for PLAC Test Reagent Kit turbidimetric immunoassay for Lp-PLA2 measurement on automated chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of Lp-PLA2 in human serum or plasma as an aid in predicting risk for coronary heart disease and ischemic stroke associated with atherosclerosis, used in conjunction with clinical evaluation and patient risk assessment",
    "fda_folder": "Immunology"
}